Lung Cancer/Thoracic Malignancies
CAMPEP Credits: 0.50
MDCB Credits: 0.50
Please find the details of each abstract that will be highlighted in this session below:
1. Abstract #: 5Title: Pirfenidone in the Treatment of Radiation-Induced Lung Injury: A Randomized, Controlled, Multicenter Clinical TrialPresenting Author: Ming Chen, MD
2. Abstract #: LBA 13Title: Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)Presenting Author: Puneeth Iyengar, MD, PhD
3. Abstract #: 193Title: Durvalumab Combined with Concurrent Chemoradiotherapy in Patients with Limited-Stage Small-Cell Lung Cancer: A Prospective, Single-Arm, Phase II Clinical Trial
Presenting Author: Wen Bin Shen, MD
4. Abstract #: 194Title: Simultaneous Integrated Boost vs. Conventional Radiotherapy for Patients with Limited-Stage Small Cell Lung Cancer: A Randomized, Non-Inferiority, Open-Label, Phase 3 TrialPresenting Author: Tianyou Zhan, MD
5. Abstract #: 188Title: Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung CancerPresenting Author: Emily Lebow, MD
Discussant: Inga Grills, MD – Corewell Health William Beaumont University Hospital